Drug Type Small molecule drug |
Synonyms Buprenorphine/granisetron + [2] |
Action antagonists, agonists |
Mechanism 5-HT3 receptor antagonists(Serotonin 3 (5-HT3) receptor antagonists), κ opioid receptor antagonists(Kappa opioid receptor antagonists), μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H24N4O |
InChIKeyMFWNKCLOYSRHCJ-BTTYYORXSA-N |
CAS Registry109889-09-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain, Postoperative | Phase 1 | Sweden | - | |
Pain, Postoperative | Phase 1 | - | - | |
Postoperative Nausea and Vomiting | Phase 1 | Sweden | - | |
Postoperative Nausea and Vomiting | Phase 1 | - | - |